122 related articles for article (PubMed ID: 19088030)
1. Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the in vivo elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate.
Vlaming ML; Pala Z; van Esch A; Wagenaar E; van Tellingen O; de Waart DR; Oude Elferink RP; van de Wetering K; Schinkel AH
Clin Cancer Res; 2008 Dec; 14(24):8152-60. PubMed ID: 19088030
[TBL] [Abstract][Full Text] [Related]
2. Functionally overlapping roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate in vivo.
Vlaming ML; Pala Z; van Esch A; Wagenaar E; de Waart DR; van de Wetering K; van der Kruijssen CM; Oude Elferink RP; van Tellingen O; Schinkel AH
Clin Cancer Res; 2009 May; 15(9):3084-93. PubMed ID: 19383815
[TBL] [Abstract][Full Text] [Related]
3. Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo.
Vlaming ML; van Esch A; Pala Z; Wagenaar E; van de Wetering K; van Tellingen O; Schinkel AH
Mol Cancer Ther; 2009 Dec; 8(12):3350-9. PubMed ID: 19996279
[TBL] [Abstract][Full Text] [Related]
4. Impact of abcc2 [multidrug resistance-associated protein (MRP) 2], abcc3 (MRP3), and abcg2 (breast cancer resistance protein) on the oral pharmacokinetics of methotrexate and its main metabolite 7-hydroxymethotrexate.
Vlaming ML; van Esch A; van de Steeg E; Pala Z; Wagenaar E; van Tellingen O; Schinkel AH
Drug Metab Dispos; 2011 Aug; 39(8):1338-44. PubMed ID: 21566011
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent disposition of methotrexate in Abcc2 and Abcc3 gene knockout murine models.
Wang Z; Zhou Q; Kruh GD; Gallo JM
Drug Metab Dispos; 2011 Nov; 39(11):2155-61. PubMed ID: 21841039
[TBL] [Abstract][Full Text] [Related]
6. Leflunomide Increases Hepatic Exposure to Methotrexate and Its Metabolite by Differentially Regulating Multidrug Resistance-Associated Protein Mrp2/3/4 Transporters via Peroxisome Proliferator-Activated Receptor
Wang L; Ma L; Lin Y; Liu X; Xiao L; Zhang Y; Xu Y; Zhou H; Pan G
Mol Pharmacol; 2018 Jun; 93(6):563-574. PubMed ID: 29618584
[TBL] [Abstract][Full Text] [Related]
7. Carcinogen and anticancer drug transport by Mrp2 in vivo: studies using Mrp2 (Abcc2) knockout mice.
Vlaming ML; Mohrmann K; Wagenaar E; de Waart DR; Elferink RP; Lagas JS; van Tellingen O; Vainchtein LD; Rosing H; Beijnen JH; Schellens JH; Schinkel AH
J Pharmacol Exp Ther; 2006 Jul; 318(1):319-27. PubMed ID: 16611851
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein (P-gp/Abcb1), Abcc2, and Abcc3 determine the pharmacokinetics of etoposide.
Lagas JS; Fan L; Wagenaar E; Vlaming ML; van Tellingen O; Beijnen JH; Schinkel AH
Clin Cancer Res; 2010 Jan; 16(1):130-40. PubMed ID: 20028753
[TBL] [Abstract][Full Text] [Related]
9. Altered hepatobiliary disposition of 5 (and 6)-carboxy-2',7'-dichlorofluorescein in Abcg2 (Bcrp1) and Abcc2 (Mrp2) knockout mice.
Nezasa K; Tian X; Zamek-Gliszczynski MJ; Patel NJ; Raub TJ; Brouwer KL
Drug Metab Dispos; 2006 Apr; 34(4):718-23. PubMed ID: 16434545
[TBL] [Abstract][Full Text] [Related]
10. Complex pharmacokinetic behavior of ezetimibe depends on abcc2, abcc3, and abcg2.
de Waart DR; Vlaming ML; Kunne C; Schinkel AH; Oude Elferink RP
Drug Metab Dispos; 2009 Aug; 37(8):1698-702. PubMed ID: 19443695
[TBL] [Abstract][Full Text] [Related]
11. Increasing systemic exposure of methotrexate by active efflux mediated by multidrug resistance-associated protein 3 (mrp3/abcc3).
Kitamura Y; Hirouchi M; Kusuhara H; Schuetz JD; Sugiyama Y
J Pharmacol Exp Ther; 2008 Nov; 327(2):465-73. PubMed ID: 18719291
[TBL] [Abstract][Full Text] [Related]
12. Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein.
de Waart DR; Häusler S; Vlaming ML; Kunne C; Hänggi E; Gruss HJ; Oude Elferink RP; Stieger B
J Pharmacol Exp Ther; 2010 Jul; 334(1):78-86. PubMed ID: 20388726
[TBL] [Abstract][Full Text] [Related]
13. Hepatic clearance of reactive glucuronide metabolites of diclofenac in the mouse is dependent on multiple ATP-binding cassette efflux transporters.
Lagas JS; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Mol Pharmacol; 2010 Apr; 77(4):687-94. PubMed ID: 20086033
[TBL] [Abstract][Full Text] [Related]
14. A Time-Dependent Model Describes Methotrexate Elimination and Supports Dynamic Modification of MRP2/ABCC2 Activity.
Woillard JB; Debord J; Benz-de-Bretagne I; Saint-Marcoux F; Turlure P; Girault S; Abraham J; Choquet S; Marquet P; Barin-Le Guellec C
Ther Drug Monit; 2017 Apr; 39(2):145-156. PubMed ID: 28196047
[TBL] [Abstract][Full Text] [Related]
15. Functional reconstitution of human ABCC3 into proteoliposomes reveals a transport mechanism with positive cooperativity.
Zehnpfennig B; Urbatsch IL; Galla HJ
Biochemistry; 2009 May; 48(20):4423-30. PubMed ID: 19334674
[TBL] [Abstract][Full Text] [Related]
16. Effect of DPC 333 [(2R)-2-{(3R)-3-amino-3-[4-(2-methylquinolin-4-ylmethoxy)phenyl]-2-oxopyrrolidin-1-yl}-N-hydroxy-4-methylpentanamide], a human tumor necrosis factor alpha-converting enzyme inhibitor, on the disposition of methotrexate: a transporter-based drug-drug interaction case study.
Luo G; Garner CE; Xiong H; Hu H; Richards LE; Brouwer KL; Duan J; Decicco CP; Maduskuie T; Shen H; Lee FW; Gan LS
Drug Metab Dispos; 2007 Jun; 35(6):835-40. PubMed ID: 17332143
[TBL] [Abstract][Full Text] [Related]
17. Analysis of methotrexate and 7-hydroxymethotrexate by high-performance liquid chromatography and preliminary clinical studies.
Collier CP; MacLeod SM; Soldin SJ
Ther Drug Monit; 1982; 4(4):371-80. PubMed ID: 6760471
[TBL] [Abstract][Full Text] [Related]
18. Association of ABCC2 -24C>T polymorphism with high-dose methotrexate plasma concentrations and toxicities in childhood acute lymphoblastic leukemia.
Liu Y; Yin Y; Sheng Q; Lu X; Wang F; Lin Z; Tian H; Xu A; Zhang J
PLoS One; 2014; 9(1):e82681. PubMed ID: 24404132
[TBL] [Abstract][Full Text] [Related]
19. Impact of basolateral multidrug resistance-associated protein (Mrp) 3 and Mrp4 on the hepatobiliary disposition of fexofenadine in perfused mouse livers.
Tian X; Swift B; Zamek-Gliszczynski MJ; Belinsky MG; Kruh GD; Brouwer KL
Drug Metab Dispos; 2008 May; 36(5):911-5. PubMed ID: 18276836
[TBL] [Abstract][Full Text] [Related]
20. Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport.
El-Sheikh AA; van den Heuvel JJ; Koenderink JB; Russel FG
J Pharmacol Exp Ther; 2007 Jan; 320(1):229-35. PubMed ID: 17005917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
